Automated covariate selection and Bayesian model averaging in population PK/PD models

Area of Science:

• Pharmacometrics
• Statistical Modeling
• Computational Biology

Background:

• Population pharmacokinetic/pharmacodynamic (PK/PD) analyses are crucial for drug development.
• Covariate selection is a critical but challenging step in PK/PD modeling.
• Automating covariate selection can improve efficiency and reliability.

Purpose of the Study:

• To demonstrate the utility of reversible jump Markov chain Monte Carlo (MCMC) for automated covariate selection in population PK/PD analyses.
• To compare the impact of model averaging versus selecting the single best model on PK/PD inferences.
• To highlight the clinical significance of differences between these modeling approaches.

Main Methods:

• Application of reversible jump MCMC algorithm for covariate model selection.
• Utilized the 'Jump' interface within WinBUGS software.
• Analyzed population PK/PD data for vancomycin in 59 neonates and infants.

Main Results:

• The reversible jump MCMC approach successfully automated covariate selection.
• Model averaging across multiple plausible models yielded different inferences compared to using only the best model.
• Quantified the uncertainty spread across all possible covariate models.

Conclusions:

• Automated covariate selection using reversible jump MCMC is feasible and effective for population PK/PD studies.
• Model averaging in PK/PD analysis can lead to clinically significant differences in drug dosing and interpretation.
• This methodology enhances the robustness and interpretability of population PK/PD models.